Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Research
[키워드] ACE inhibitor
ACEi
adjusted odds ratio
Admission
angiotensin receptor antagonists
angiotensin receptor blocker
angiotensin-converting enzyme inhibitor
angiotensin-converting enzyme inhibitors
ARB
Care
Clinical outcome
Clinical severity
Cohort
Comorbidity
confidence interval
coronavirus disease
Coronavirus infections
COVID-19
death
evaluate
events
Guidance
hypertension
hypertensive
increased risk
indicated
intensive care
lower risk
medication
multivariable
Older
outcome
outcomes
pandemic
Patient
patients with COVID-19
polymerase chain
Prevalence
real time
Result
reverse transcription
risk
significantly higher
study outcomes
Treatment
ventilator
with COVID-19
[DOI] 10.1186/s40885-021-00168-0 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s40885-021-00168-0 PMC 바로가기 [Article Type] Research